84078 CPT® code: payer coverage and prior authorization84078 appears in 7 coverage policies from Aetna, Blue Cross NC, Blue Shield of California, Cigna, Premera Blue Cross.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Biochemical Markers of Bone Remodeling (0562) | not covered (range 84075-84080) | Aug 21, 2026 | payer document |
| Aetna | Etranacogene Dezaparvovec-drlb (Hemgenix) (1023) | listed, no stance | Apr 17, 2026 | payer document |
| Aetna | Zoledronic Acid (0524) | listed, no stance | Feb 12, 2026 | payer document |
| Blue Cross NC | Professional Pathology Billing Requirements AHS – R2169 | listed, no stance (range 84030-84999) | Mar 1, 2024 | payer document |
| Blue Shield of California | Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated With High Bone Turnover (2.04.15) | listed, no stance | payer document | |
| Cigna | Laboratory Testing Services (0604) | not covered | May 15, 2026 | payer document |
| Premera Blue Cross | Serum Tumor Markers for Malignancies | listed, no stance | Oct 1, 2026 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.